PKTX (ProtoKinetix) Margin of Safety % (DCF Dividends Based) : N/A (As of May. 01, 2025)

View and export this data going back to 2017. Start your Free Trial

What is ProtoKinetix Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

ProtoKinetix's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

Competitive Comparison of ProtoKinetix's Margin of Safety % (DCF Dividends Based)

For the Biotechnology subindustry, ProtoKinetix's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProtoKinetix's Margin of Safety % (DCF Dividends Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProtoKinetix's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where ProtoKinetix's Margin of Safety % (DCF Dividends Based) falls into.

Save Embed

;

Save Embed

;

ProtoKinetix Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of ProtoKinetix's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

ProtoKinetix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProtoKinetix Inc (OTCPK:PKTX) » Definitions » Margin of Safety % (DCF Dividends Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

109 W Main Street, Dalton, OH, USA, 44618

Website

https://www.protokinetix.com

ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.

Executives

Clarence Edward Smith	director, 10 percent owner, officer: President & CEO	1845 COUNTY ROAD #214, ST. AUGUSTINE FL 32084
Michael Richard Guzzetta	officer: CFO	412 MULBERRY STREET, MARIETTA OH 45750
Lachlan Grant Young	10 percent owner	6438 ROSEBERY AVE., WEST VANCOUVER A1 V7W2C6
Edward P. Mcdonough	director	1226 WASHINGTON AVENUE, PARKERSBURG WV 26101
Susan Marie Woodward	officer: CFO	705 DUGAN ROAD, BELPRE OH 45714
Peter Krogh Jensen	director	4656 HOSKINS ROAD, NORTH VANCOUVER A1 V7K 2R1
Ian Thomas Gregory	director	2225 FOLKESTONE WAY, WEST VANCOUVER A1 V7S 2Y6
Ross Laurence Senior	director, officer: CEO	PH-3, 5688 DALHOUISE ROAD, VANCOUVER A1 V6T 1W4
Mark L Baum	director, officer: President	C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130

ProtoKinetix Headlines

From GuruFocus

Insider Buying: ProtoKinetix Inc CEO and 10% Owner Clarence Smith Acquires 3,750,000 Shares

By GuruFocus Research • 05-26-2023

Insider Buying: ProtoKinetix Inc CEO and 10% Owner Clarence Smith Acquires 3,750,000 Shares

By GuruFocus Research GuruFocus Editor • 05-25-2023